BioSante is enrolling women in three Stage III clinical research with a fresh drug application prepared for mid-2011. We believe LibiGel could be first product to advertise for this unmet medical want. Snabes.. BioSante Pharmaceuticals’ LibiGel clinical revise to be presented in 2010 ISSWSH annual meeting BioSante Pharmaceuticals, Inc. Petersburg, Florida. BioSante is in Stage III advancement of LibiGel for the treating hypoactive libido disorder in menopausal females under an FDA approved SPA .The Associated Press: Calif. Eases Secrecy Guidelines Around Health Agreements Gov. Jerry Brown signed legislation Tuesday stripping broad secrecy provisions from the condition agency overseeing health care reform in California that gave it the energy to shield from the public how hundreds of millions of dollars are spent. The Democratic governor signed the expenses on the same day time online insurance marketplaces that are in the center of President Barack Obama's health care overhaul went into business around the country . This article was reprinted from kaiserhealthnews.org with permission from the Henry J.